Showing results (341-350 of 368) with videos related to

Sort By:
Pageof 37
Journal of Biochemistry|January 8, 2025
Identification of a novel Eps 15 homology domain-containing protein 1 (EHD1) and EHD4-binding motif in phostensinKuang-Yung Huang, Hui-Chun Yu, Ming-Chi Lu, et al.
International Journal of Surgery (London, England)|October 14, 2025
Proposal of a novel model for identifying complete response and nonoperative management in DMMR colon cancer following neoadjuvant immunotherapy: a retrospective cohort studyLe-En Liao, Li-Li Feng, Bi-Yun Chen, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 12, 2025
Prognostic Significance of SOX9 and Its Combination With RAS and TP53 Mutations Following Colorectal Cancer Liver MetastasectomyJian-Li Duan, Lei Wen, Yan-Yu Cai, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2022
Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort studyQiao-Xuan Wang, Bin-Yi Xiao, Yong Cheng, et al.
Annals of Translational Medicine|March 12, 2021
Primary tumor immune score fails to predict the prognosis of colorectal cancer liver metastases after hepatectomy in Chinese populationsHao-Cheng Lin, Qiong Shao, Jie-Ying Liang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 18, 2024
Long-Term Outcomes of dMMR/MSI-H Rectal Cancer Treated With Anti-PD-1-Based Immunotherapy as Curative-Intent TreatmentJie-Hai Yu, Le-En Liao, Bin-Yi Xiao, et al.
The Lancet. Oncology|June 9, 2024
Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 studyJie-Hai Yu, Bin-Yi Xiao, Dan-Dan Li, et al.
Nature Cell Biology|June 5, 2019
Mapping phospho-catalytic dependencies of therapy-resistant tumours reveals actionable vulnerabilitiesJean-Philippe Coppé, Miki Mori, Bo Pan, et al.
Journal of Cancer Research and Clinical Oncology|August 30, 2017
Safety of intraoperative chemotherapy with 5-FU for colorectal cancer patients receiving curative resection: a randomized, multicenter, prospective, phase III IOCCRC trial (IOCCRC)Rong-Xin Zhang, Jun-Zhong Lin, Jian Lei, et al.
BMC Medicine|October 25, 2021
A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort studyLian-Jing Cao, Xiao-Lin Peng, Wen-Qiong Xue, et al.
Pageof 37